We also observed CXCR4 downregulation on CLL B cells from patients with a poor prognosis when they were co-cultured with MSCs, as well as an increase in CD69 surface expression (166). This evidence concerns the gene CXCR4 and B-cell chronic lymphocytic leukemia.